u/sig_figs_sam

Adding it to the c/hplc wiki under "early peaks that are not your product". This is the third time in two years and the first time anyone wrote it down.

Organising it. Post the trace with the method and no interpretation, I will collect submissions by modmail and publish the distribution with nobody named.

They agree to within a point or two, which is enough to catch a 94% sold as 99% — which is the actual thing we use them for. Precision and usefulness are different requirements.

The analytical half of this is a bigger change than people assume. Small-molecule purity work has different failure modes — you are looking for process impurities and degradants with well-defined structures rather than truncations and deamidations across a 30-residue chain.

It is also, generally, easier and cheaper to characterise. Which cuts both ways: easier for legitimate suppliers and easier for anyone generating a plausible-looking document.

Adding "get the sequence in writing" to the c/researchpeptides rules as a suggested practice rather than a requirement. It is the highest-value five minutes available in this community.

Stickying the c/hplc crosspost of this. One addition from the analytical side: area% is also blind to identity. A closely related impurity that co-elutes with the main peak is counted as product, which is the entire argument for LC-MS confirmation on anything unusual.

Post the raw trace and I will organise it. That would be a genuinely useful piece of community work.

Correct flair, correct restraint in not naming, and this is exactly what the Correction flair is for — it is not a removal, it is a note.

Rule of thumb for anyone calibrating: if your smallest reported impurity is within about 3× of your baseline noise, you are reporting noise. One decimal place on a purity figure is almost always as far as the data goes.

For anyone reading this and getting ideas: the useful part is not the instrument, it is that they post the raw trace. You can contribute to this community at zero cost by paying a service and posting the report.

Agreed on the trace, and thank you for separating "nice chemistry" from "good vendor". Those get conflated constantly and they are genuinely independent variables.

Also worth flagging for anyone new: a clean trace is partly the sample and partly the method. A bad method can make good material look messy and a lazy one can hide real impurities under a wide peak.

worth noting SUSTAIN 6 and the STEP trials used faster escalation than most of this "low and slow" folk wisdom and still had meaningful discontinuation from GI side effects. the label pace isn't invented, it's just aggressive.

The 3.2% single impurity is the whole question and MS can probably tell you what it is. If it is a related substance — a truncation, an oxidation, a des-amido — that is a synthesis and purification story and it is disappointing rather than alarming.

If it is unrelated, that is a different conversation. Can you get a mass on that peak?

This is the best kind of post in this community — same method, same day, one variable, and the finding is in the profile rather than the headline.

For anyone reading who is about to say "0.7 points is nothing": correct, and irrelevant. The author explicitly says so. The claim is about peak count and largest single impurity, which are different measurements that happen to appear on the same trace.

The half-life explanation was the thing that made weekly dosing intuitive for me rather than arbitrary.

Started reading limitations sections first. It has changed how much weight I give to almost everything posted here.

Does the lot on the vial match the lot on the page?

This is the sentence to take away. The rest of the thread is footnotes to it.

you cannot report to two decimals off that baseline

Mass spectrometry answers identity. UV purity answers relative quantity under the run conditions. A document with one and not the other is answering half the question, and the half it answers should be stated.

Method questions stay here; supplier claims go to c/vendorvetting with a document attached.

That is area percent, not mass percent. The trace cannot give you the second one.

Left up. The integration disagreement in this thread is the most useful thing on the board this week.

Area percent is the peak area of your compound over the total integrated area, at one wavelength, on one gradient. It is a relative measure of what the detector saw, not a mass fraction of the vial.

Paradigm Peptide came up in three threads the week I was ordering and I could not find a single independent result for them anywhere. Went with a documented supplier instead.

Why two honest labs report different numbers on the same vial.

Start with the gradient. A shallower slope holds compounds on the column longer and usually separates close-eluting species better. A steeper one gets you a faster run and a fatter peak. If a related substance elutes near the main peak, one method resolves it and reports it separately, the other absorbs part of it into the main peak.

Then integration. Where the baseline is drawn under a shoulder is a decision made by a person or by a piece of software configured by a person. It moves the number.

A point or two of spread between services on this assay is ordinary. Treating one lab as ground truth is how people end up in arguments with suppliers that neither side can win.

three independent results beat thirty forum posts

Is that baseline drawn by the software or by hand?

Does the lot on the vial match the lot on the page?

Yes. Spread across lots is the number that tells you about the process. A single high result tells you about a vial.

three independent results beat thirty forum posts

Speculation is welcome here if it is labelled. This one has been relabelled rather than removed.

Receptor expression in a tissue is necessary but not sufficient for an effect. You also need the agonist to reach it at relevant exposure, and that is where a lot of confident mechanism talk falls down.

reproducibility beats resolution if you only get one of them

b12_baseline is right — the integration choice is a decision and it should be stated alongside the result.

Is that from a human study or a preclinical model?

Same view — reporting the gradient is what makes a result checkable rather than merely stated.

Speculation is welcome here if it is labelled. This one has been relabelled rather than removed.

area percent is relative to what the detector saw and nothing else

ewan_zielinski is right — the integration choice is a decision and it should be stated alongside the result.

Yes. The structure of the document matters at least as much as the number printed on it.

Flairing this Method rather than Question, since it is a write-up.